Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Weinstein

Showing results (991-1000 of 1,016) with videos related to

Pageof 102
Sort By:
Nature Medicine|August 25, 2014
The G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog-driven medulloblastomaXuelian He, Liguo Zhang, Ying Chen, et al.
Journal of Medicinal Chemistry|July 18, 2019
Identification of <i>N</i>-Methyl Nicotinamide and <i>N</i>-Methyl Pyridazine-3-Carboxamide Pseudokinase Domain Ligands as Highly Selective Allosteric Inhibitors of Tyrosine Kinase 2 (TYK2)Ryan Moslin, Yanlei Zhang, Stephen T Wrobleski, et al.
Elife|April 18, 2017
Oriented clonal cell dynamics enables accurate growth and shaping of vertebrate cartilageMarketa Kaucka, Tomas Zikmund, Marketa Tesarova, et al.
The Journal of Clinical Investigation|June 17, 2025
β Cell Gαs signaling is critical for physiological and pharmacological enhancement of insulin secretionMegan E Capozzi, David Bouslov, Ashot Sargsyan, et al.
Head & Neck|June 26, 2020
Penn Medicine Head and Neck Cancer Service Line COVID-19 management guidelinesGregory S Weinstein, Roger Cohen, Alexander Lin, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2023
Structure-activity relationship study of central pyridine-derived TYK2 JH2 inhibitors: Optimization of the PK profile through C4' and C6 variationsZili Xiao, Michael G Yang, Chunjian Liu, et al.
Head & Neck|September 28, 2012
Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, VirginiaDavid J Adelstein, John A Ridge, David M Brizel, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 29, 2013
Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral ResearchElizabeth Shane, David Burr, Bo Abrahamsen, et al.
Science Translational Medicine|July 26, 2019
Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domainJames R Burke, Lihong Cheng, Kathleen M Gillooly, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Identification of Imidazo[1,2-<i>b</i>]pyridazine Derivatives as Potent, Selective, and Orally Active Tyk2 JH2 InhibitorsChunjian Liu, James Lin, Ryan Moslin, et al.
Pageof 102

Showing results (991-1000 of 1,016) with videos related to

Sort By:
Pageof 102
Nature Medicine|August 25, 2014
The G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog-driven medulloblastomaXuelian He, Liguo Zhang, Ying Chen, et al.
Journal of Medicinal Chemistry|July 18, 2019
Identification of <i>N</i>-Methyl Nicotinamide and <i>N</i>-Methyl Pyridazine-3-Carboxamide Pseudokinase Domain Ligands as Highly Selective Allosteric Inhibitors of Tyrosine Kinase 2 (TYK2)Ryan Moslin, Yanlei Zhang, Stephen T Wrobleski, et al.
Elife|April 18, 2017
Oriented clonal cell dynamics enables accurate growth and shaping of vertebrate cartilageMarketa Kaucka, Tomas Zikmund, Marketa Tesarova, et al.
The Journal of Clinical Investigation|June 17, 2025
β Cell Gαs signaling is critical for physiological and pharmacological enhancement of insulin secretionMegan E Capozzi, David Bouslov, Ashot Sargsyan, et al.
Head & Neck|June 26, 2020
Penn Medicine Head and Neck Cancer Service Line COVID-19 management guidelinesGregory S Weinstein, Roger Cohen, Alexander Lin, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2023
Structure-activity relationship study of central pyridine-derived TYK2 JH2 inhibitors: Optimization of the PK profile through C4' and C6 variationsZili Xiao, Michael G Yang, Chunjian Liu, et al.
Head & Neck|September 28, 2012
Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, VirginiaDavid J Adelstein, John A Ridge, David M Brizel, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 29, 2013
Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral ResearchElizabeth Shane, David Burr, Bo Abrahamsen, et al.
Science Translational Medicine|July 26, 2019
Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domainJames R Burke, Lihong Cheng, Kathleen M Gillooly, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Identification of Imidazo[1,2-<i>b</i>]pyridazine Derivatives as Potent, Selective, and Orally Active Tyk2 JH2 InhibitorsChunjian Liu, James Lin, Ryan Moslin, et al.
Pageof 102